Genetic and metabolic medicine
Hereditary spastic paraparesis and spinocerebellar ataxia
Recognising hereditary spastic paraparesis and the dominant spinocerebellar ataxias, the treatable mimics to exclude first, which genetic test to order (and why exome misses repeat expansions), symptomatic care and predictive testing.
Tier 2Condition
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- Both are inherited, slowly progressive neurodegenerative disorders that present in adult clinics as an unexplained gait disorder with a family history. Neither has a disease-modifying treatment, so the physician's job is to exclude treatable mimics, choose the right genetic test, organise symptomatic and disability support, and arrange counselling for relatives.
- HSP is a length-dependent degeneration of the corticospinal tracts: spastic legs, preserved arms.
- SCAs are mostly autosomal dominant repeat expansion disorders of the cerebellum and its connections. The general approach to ataxia and the other genetic ataxias (Friedreich, CANVAS, FXTAS) is in cerebellar disorders.
Loading the rest of the note…
Finished reading?
Sources
- Srinivasan SR, Mook AD, Rochman M et al. Practice recommendations for genetic testing of ataxias. Ann Clin Transl Neurol 2025;12(12):2398-2409Annals of Clinical and Translational Neurology, 2025
- Hereditary spastic paraplegia overview (GeneReviews, updated 2025)University of Washington, Seattle (NCBI Bookshelf), 2025
- Pellerin D, Danzi MC, Wilke C et al. Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia. N Engl J Med 2023;388:128-141New England Journal of Medicine, 2023
- Wilke C, Pellerin D et al. GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response. Brain 2023;146(10):4144-4157Brain, 2023
- Hereditary ataxia overview (GeneReviews)University of Washington, Seattle (NCBI Bookshelf)
- Shribman S, Reid E, Crosby AH, Houlden H, Warner TT. Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches. Lancet Neurol 2019;18:1136-1146The Lancet Neurology, 2019
- MJD Foundation (Machado-Joseph disease and SCA7 in Aboriginal and Torres Strait Islander communities)AU/NZMJD Foundation
- Legislation passed to ban the use of adverse genetic testing results in life insurance (ministerial media release)AU/NZAustralian Government, The Treasury, 2026
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback